4//SEC Filing
Young David 4
Accession 0000897069-25-001215
CIK 0001533743other
Filed
Jul 27, 8:00 PM ET
Accepted
Jul 28, 4:28 PM ET
Size
5.6 KB
Accession
0000897069-25-001215
Insider Transaction Report
Form 4
Young David
DirectorPres. Research & Development
Transactions
- Award
Restricted Stock Units
2025-07-24+1,813,133→ 1,821,016 totalExercise: $0.00→ Common Stock (1,813,133 underlying)
Footnotes (2)
- [F1]Restricted stock granted under the Processa Pharmaceuticals, Inc. 2019 Omnibus Incentive Plan ("Omnibus Plan"), of which 1,790,833 shares are subject to stockholder approval of the revised Omnibus Plan.
- [F2]Each Restricted Stock Unit represents a contingent right to receive one share of the Issuer's common stock, following its vesting on of one-third on January 1, 2026, and one-thirty-sixth each month thereafter until fully vested on January 1, 2028.
Documents
Issuer
Processa Pharmaceuticals, Inc.
CIK 0001533743
Entity typeother
Related Parties
1- filerCIK 0001378166
Filing Metadata
- Form type
- 4
- Filed
- Jul 27, 8:00 PM ET
- Accepted
- Jul 28, 4:28 PM ET
- Size
- 5.6 KB